In this report, we review the clinical, biochemical, pathophysiologic, and therapeutic aspects of cerebrotendinous xanthomatosis. We stress the importance of early diagnosis and treatment. In addition, we describe our experience in treating patients with chenodeoxycholic acid, an essential drug for this disorder that is no longer available
Abstract Background Cerebrotendinous xanthomatosis (CTX) is a rare, chronic, progressive, neurodegen...
OBJECTIVE: To evaluate the effect of chenodeoxycholic acid treatment on disease progression in cereb...
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease caused by deficiency of sterol 27-hy...
In this report, we review the clinical, biochemical, pathophysiologic, and therapeutic aspects of ce...
We read with interest the NeuroImage report,1 Letter to the Editor,2 and Reply from the Authors3 on ...
peer reviewedCerebrotendinous xanthomatosis (CTX) is a rare and treatable autosomal recessive diseas...
We describe a patient with cerebrotendinous xanthomatosis (CTX) who saw a Rheumatologist because of ...
Contains fulltext : 146723.pdf (Publisher’s version ) (Open Access)178 p
The authors report the clinical findings in 10 Italian cases of cerebrotendinous xanthomatosis (CTX)...
Aim: The primary purpose of the present study is to evaluate the effect of chenodeoxycholic acid tre...
Cerebrotendinous xanthomatosis (CTX) is a rare and treatable autosomal recessive disease. The diagno...
We report the electrophysiological follow-up of five cerebrotendinous xanthomatosis patients treated...
International audienceCerebrotendinous xanthomatosis (CTX) is a rare and severe, but treatable, inbo...
Cerebrotendinous Xanthomatosis(CTX) is an uncommon autosomal recessive disorder in which there is ac...
Cerebrotendinous xanthomatosis (CTX) is a metabolic disease characterized by systemic signs and neur...
Abstract Background Cerebrotendinous xanthomatosis (CTX) is a rare, chronic, progressive, neurodegen...
OBJECTIVE: To evaluate the effect of chenodeoxycholic acid treatment on disease progression in cereb...
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease caused by deficiency of sterol 27-hy...
In this report, we review the clinical, biochemical, pathophysiologic, and therapeutic aspects of ce...
We read with interest the NeuroImage report,1 Letter to the Editor,2 and Reply from the Authors3 on ...
peer reviewedCerebrotendinous xanthomatosis (CTX) is a rare and treatable autosomal recessive diseas...
We describe a patient with cerebrotendinous xanthomatosis (CTX) who saw a Rheumatologist because of ...
Contains fulltext : 146723.pdf (Publisher’s version ) (Open Access)178 p
The authors report the clinical findings in 10 Italian cases of cerebrotendinous xanthomatosis (CTX)...
Aim: The primary purpose of the present study is to evaluate the effect of chenodeoxycholic acid tre...
Cerebrotendinous xanthomatosis (CTX) is a rare and treatable autosomal recessive disease. The diagno...
We report the electrophysiological follow-up of five cerebrotendinous xanthomatosis patients treated...
International audienceCerebrotendinous xanthomatosis (CTX) is a rare and severe, but treatable, inbo...
Cerebrotendinous Xanthomatosis(CTX) is an uncommon autosomal recessive disorder in which there is ac...
Cerebrotendinous xanthomatosis (CTX) is a metabolic disease characterized by systemic signs and neur...
Abstract Background Cerebrotendinous xanthomatosis (CTX) is a rare, chronic, progressive, neurodegen...
OBJECTIVE: To evaluate the effect of chenodeoxycholic acid treatment on disease progression in cereb...
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease caused by deficiency of sterol 27-hy...
DOI
Add to ORKG